The company, which obtained a Singapore listing early last month after a reverse takeover of small-scale healthcare provider Ezyhealth Asia Pacific, on Monday July 31 priced its shares slightly below the top of the range at S$0.80 apiece to reflect some price sensitivity in the book and the still volatile secondary markets.
That said, the offer attracted a lot of attention from investors because of the companyÆs strong position throughout the palm oil value chain, from plantations to various end products like cooking...
¬ Haymarket Media Limited. All rights reserved.
